feed,title,long_url,short_url
r/pennystocks:25+,"[:Bagger: Bullish] NEWS: $SNGX reports broad efficacy and improved safety profile of HyBryte, an agent still in the pipeline for Cutaneous T-Cell Lymphoma (CTCL)",https://redd.it/n4t4e9,
